Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)

Open Date (Earliest Submission Date): April 07, 2025
Expiration Date: January 08, 2028

Funds Available and Anticipated Number of Awards

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

This NOFO is soliciting R01 applications that support a discrete, specified, circumscribed project (up to 5 years) to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies. The companion R21 NOFO (PAR-25-316) will support shorter term (up to 2 years) exploratory/developmental research activities. All R01 applications should provide preliminary data to support hypotheses and/or justify any descriptive studies. 

Award Budget

Application budgets are not limited but need to reflect the actual needs of the proposed project.

Award Project Period

The scope of the proposed project should determine the project period. The maximum project period is five years.

Additional details about the R01 can be found here.